Literature DB >> 4115582

Generic equivalence and non-equivalence of drugs.

R N Smith.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4115582     DOI： 10.1016/s0140-6736(72)91919-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Bioavailability of commercial tetracycline products.

Authors:  D B Barnett; R N Smith; N D Greenwood; C Hetherington
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

2.  Which drugs should we be testing for bioavailability.

Authors:  R N Smith
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

3.  Effects of different rates of absorption of two benzodiazepins on subjective and objective parameters. Significance for clinical use and risk of abuse.

Authors:  A Bliding
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

4.  Biological availability of digoxin from Lanoxin produced in the United Kingdom.

Authors:  B F Johnson; A S Fowle; S Lader; J Fox; A D Munro-Faure
Journal:  Br Med J       Date:  1973-11-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.